Showing results (641-650 of 8,737) with videos related to
Sort By:
Pageof 874
Terapevticheskii Arkhiv|August 5, 2005
[The role of polymorphic markers of vasoactive hormones genes in clinical characteristics of chronic glomerulonephritis]E S Kamyshova, I M Kutyrina, V V Nosikov, et al.Terapevticheskii Arkhiv|August 5, 2005
[Arterial hypertension in clinical assessment of ischemic renal disease]Terapevticheskii Arkhiv|December 5, 2022
[Clinical-anthropometric and laboratory-instrumental characteristics of iron deficiency states in children with celiac disease]T A Ivenskaya, L Y Klimov, V A Kuryaninova, et al.Terapevticheskii Arkhiv|December 5, 2022
[Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus]O I Vengrzhinovskaya, I Z Bondarenko, O A Shatskaya, et al.Terapevticheskii Arkhiv|December 5, 2022
[Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease]M S Shamkhalova, O Y Sukhareva, M V ShestakovaTerapevticheskii Arkhiv|December 5, 2022
[Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy]M S Sheremeta, M O Korchagina, E D Pesheva, et al.Terapevticheskii Arkhiv|December 6, 2022
[Antithrombotic therapy of coronary heart disease: time - tested essential principles]E P PanchenkoTerapevticheskii Arkhiv|December 6, 2022
[The evolution of myocardial infarction treatment over the past decades. The significance of E.I. Chazov works]R M Shakhnovich, M Y RudaTerapevticheskii Arkhiv|December 6, 2022
[Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease]S V Moiseev, E A Karovaikina, N M Bulanov, et al.Terapevticheskii Arkhiv|December 6, 2022
[Clinical and pathologic features of nephropathy with C1q deposits]N V Chebotareva, A A Vinogradov, A N Grishina, et al.Pageof 874